1. Home
  2. Companies
  3. H1 Insights

About

H1 Insights operates a healthcare data platform that covers 9 million healthcare professionals globally, democratizing access to data and connecting stakeholders within the healthcare ecosystem. The platform enables users to find and engage with providers and researchers for various applications.

It assists customers in identifying key opinion leaders, accelerating clinical trials, and supporting scientific decision-making. The company serves industry verticals such as life sciences, hospitals, academic medical centers, and health systems.

Based in New York, H1 Insights has a team of over 400 employees focused on improving healthcare through better data-driven connections and insights.

Similar companies

Health Catalyst logoHC

Health Catalyst

Healthcare data and analytics company founded in 2008, using AI and a cloud-based platform to unify clinical, financial and operational data for more than 1,000 healthcare organisations.

Paradigm Health logoPH

Paradigm Health

Paradigm Health develops an intelligent research platform using clinical research technology and healthcare data integration to connect patients, providers, and trial sponsors, improving clinical trial efficiency and access.

PulsePoint logoPU

PulsePoint

PulsePoint builds healthcare marketing technology that uses data analytics and machine learning to connect pharmaceutical brands with healthcare professionals and consumers.

Arcadia logoAR

Arcadia

Arcadia is a healthcare data company that uses AI and cloud technology to transform diverse healthcare data into a unified foundation for analytics and insights.

Clarify Health logoCH

Clarify Health

Clarify Health is a San Francisco-based healthcare analytics company using AI and a data platform covering 300 million patient lives to help providers, payers and life sciences firms make clearer decisions.

Novellia logoNO

Novellia

Novellia is an AI-enabled health data company that provides patients with rapid access to their health records and partners with biopharmaceutical companies for data-driven insights.